Key Points

  • Part I provides long-term trends in cancer incidence rates (new cases) and mortality rates (deaths) for all races combined.
    • Researchers found continued declines in cancer mortality rates for men, women, and children.
    • Overall cancer incidence rates continued to decrease among men and remained stable among women.
  • Part II highlights recent changes in prostate cancer trends and disease characteristics, such as stage, clinical extension, prostate-specific antigen (PSA), and Gleason score.
    • After a decrease in PSA test usage, incidence rates of late-stage disease increased and the decline in prostate cancer mortality stabilized.

Related Resources